Lawyers

Marcie A. Goldstein

Lawyers

Filters

Aziyo Biologics $50 million IPO

Davis Polk advised the representatives of the several underwriters in connection with the $50 million initial public offering of common stock by Aziyo Biologics, Inc. The common stock…

PIMCO Dynamic Income Fund follow-on offering

Davis Polk advised the representative of the several underwriters in connection with an SEC-registered offering of shares of beneficial interest of PIMCO Dynamic Income Fund for total…

Vy Global Growth $575 million IPO

Davis Polk advised the underwriters in connection with the $575 million initial public offering of 57,500,000 units of Vy Global Growth, which includes 7,500,000 units from the full…

AEA-Bridges Impact $400 million IPO

Davis Polk advised the representatives of the underwriters in connection with the initial public offering of 40,000,000 units of AEA-Bridges Impact Corp. for aggregate proceeds of $400…

Beam Therapeutics $127 million offering

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 5,750,000 common shares of Beam Therapeutics Inc. for total gross proceeds of $127…

Mission Produce $96 million IPO

  Davis Polk advised the representatives of the several underwriters in connection with the $96 million initial public offering by Mission Produce, Inc. of 8,000,000 shares of its…

Qell Acquisition $380 million IPO

Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 33,000,000 units of Qell Acquisition Corp., for aggregate proceeds…

GoodRx Holdings $1.3 billion IPO

Davis Polk advised the representatives of the several underwriters in connection with the $1.3 billion initial public offering of 39,807,691 shares of Class A common stock of GoodRx…

Humanigen stock offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,200,000 shares of common stock of…
Back to top